Teal Health raises $22m Series A led by .406 Ventures
The financing brings total funding to $45m for its at-home screening service.
Teal Health has raised $22 million in Series A funding led by .406 Ventures. Emerson Collective, whose investment is managed by Yosemite, Forerunner and Serena Ventures returned, while MPower Partners joined as a new backer.
The company is expanding access to its FDA-authorized Teal Wand for at-home HPV sample collection. The financing comes as Teal prepares for broader insurance coverage in 2027.
Use of funds
Expand payor, provider, employer and health-system partnerships
Scale access to at-home screening